Winship urges COVID-19 vaccine prioritization for cancer patients and survivors

On Feb. 17, Winship joined in a letter to the Biden Administration to underscore the importance of prioritizing cancer patients and survivors with access to COVID-19 vaccines. The letter was signed by more than 130 scientific organizations, NCI-designated cancer centers, patient advocacy groups, and colleagues across the country.

Faculty stories highlighted during Black History Month

In honor of Black History Month, Emory University School of Medicine is highlighting the stories of six outstanding faculty members, including Winship members Drs. Kimberly Curseen and Allan Pickens.

Gullatte interviewed for Oncology Nursing Society

Mary Gullatte, PhD, RN, FAAN reflects on her 40-year career in nursing, including being first the African American president of the Oncology Nursing Society, in an interview with ONS Voice published on Feb. 15.

Modernizing cancer clinical trial eligibility criteria

R. Donald Harvey, PharmD, and colleagues from American Society of Clinical Oncology (ASCO) and Friends of Cancer Research, recently published a series of recommendations in Clinical Cancer Research that focus on making cancer clinical trials more accessible to patients. Harvey is first author of the recommendation on washout periods and concomitant medication allowance.

Downregulation of DR4 linked to response in EGFR-targeted therapy

Winship researchers, including first author Shuo Zhang and senior author Shi-Yong Sun, PhD, found that downregulation of death receptor 4 (DR4) is associated with positive efficacy of EGFR-targeted therapy and predicts improved prognosis in EGFR-mutant non-small cell lung cancer. The study was published on Feb. 15 in Theranostics.

NCI marks 50 years of National Cancer Act

The National Cancer Institute (NCI) is commemorating the 50th anniversary of the National Cancer Act of 1971, legislation that established networks of cancer centers, clinical trials, data collection systems, and advanced research. Throughout the year, NCI will share stories of progress and the people who have made progress possible.

Esiashvili helps launch WHO childhood cancer initiative

Natia Esiashvili, MD served as a panelist for the World Health Organization (WHO)'s virtual launch of CureAll, an initiative that includes a suite of tools to help countries improve diagnosis and treatment of cancer among children. The event was held on International Childhood Cancer Day, Feb. 15.

About CureAll

$hark Tank competition fuels new cancer drug discovery

The 3rd annual Winship Discovery and Developmental Therapeutics (DDT) Program $hark Tank, held virtually on Feb. 19, showcased innovative concepts for prioritizing compounds and accelerating anticancer drug discovery. Three investigators were selected to each receive $6,500 in seed funding for their proposals: Pratyusha Mandal, PhD (“Curing Chemotherapy Resistance Through Inflammation”), Jie Song, PhD (“A Potent First-In-Class Agent to Treat Cisplatin-Resistant Cancers”), and Egal Gorse, MD ("A Phase II Trial of FLT3 Inhibitor Priming in Patients with IDH2 mutated Acute Myeloid Leukemia”).

About the DDT Program

IASLC meeting focuses on targeted therapies in lung cancer

Drs. Suresh Ramalingam, Jeff Bradley, Kristin Higgins, Taofeek Owonikoko, Jennifer Carlisle, Conor Steuer were among the presenters at the International Association for the Study of Lung Cancer (IASLC) Targeted Therapies in Lung Cancer virtual meeting, held Feb. 17-20.

About the Meeting

Call for proposals: Lung Cancer SPORE pilot grants

The Winship Lung Cancer Specialized Program of Research Excellence (SPORE) offers two pilot grants of up to $50,000 each to support projects focused on career enhancement or developmental research in the area of lung cancer. Applications for both grants are due April 9.

Learn More

What's new | IDDI Shared Resource

Intervention Development, Dissemination and Implementation (IDDI), one of Winship’s 11 shared resources offering advanced research technologies and services, supports researchers in the planning, conduct, and analysis of behavioral science data. IDDI has 16 iPads, four of which are cellular capable, which can be loaned out for various research purposes. Contact IDDI to learn more about technology and services to support your research.

Learn More